SEARCH

SEARCH BY CITATION

References

  • 1
    Belle SH, Beringer KC, Detre KM. An update on liver transplantation in the United States: recipient characteristics and outcome. In: TerasakiPI, CeckaJM, eds. Clinical Transplants 1995. Los Angeles CA: UCLA Tissue Typing Laboratory, 1996;1934.
  • 2
    Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103:317322.MEDLINE
  • 3
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, et al. Long term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334:815819.MEDLINE
  • 4
    Johnson MW, Washburn K, Freeman RB, FitzMaurice SE, Dienstag J, Basgoz N, Jenkins RL, et al. Hepatitis C viral infection in liver transplantation. Arch Surg 1996; 131:284291.MEDLINE
  • 5
    Schluger LK, Sheiner PA, Thung SN, Min A, Wolf D, Fiel I, Zhang D, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23:971976.MEDLINE
  • 6
    Gane EJ, Naoumov NV, Qian K, Mondelli MU, Maertens G, Portmann BC, Lau JY, et al. A longitudinal analysis of hepatitis C virus replication after liver transplantation. Gastroenterology 1996; 110:167177.MEDLINE
  • 7
    Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106:994999.MEDLINE
  • 8
    Lau JY, Davis GL, Brunson ME, Qian KP, Lin HJ, Quan SM, DiNello R, et al. Hepatitis C virus infection in kidney transplant recipients. Hepatology 1993; 18:10271031.MEDLINE
  • 9
    Wright TL, Combs C, Kim M, Ferell L, Bacchetti P, Ascher N, Roberts J, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20:773779.MEDLINE
  • 10
    Feray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reynes M, et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 1995; 22:10841089.MEDLINE
  • 11
    Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341:15011504.MEDLINE
  • 12
    Lau JY, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171:281289.MEDLINE
  • 13
    Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, et al. A proposed system for the nomenclature of hepatitis C viral genotypes [Letter]. Hepatology 1994; 19:13211324.MEDLINE
  • 14
    DiBisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14:969974.MEDLINE
  • 15
    Kiysawa K, Akahane Y, Nagata A, Koike Y, Furuta S. The significance of blood transfusion in non-A, non-B chronic liver disease in Japan. Vox Sang 1982; 43:4552.MEDLINE
  • 16
    Greenson JK, Svoboda-Newman SM, Merion RM, Frank TS. Histologic progression of recurrent hepatitis C in liver transplant allografts. Am J Surg Pathol 1996; 20:731738.MEDLINE
  • 17
    Sheiner PA, Schluger LK, Emre S, Thung S, Lau YN, Guy SR, Schwartz ME, et al. Retransplantation for recurrent hepatitis C. Liver Transplant Surg 1997; 3:130136.
    Direct Link:
  • 18
    Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20:11371143.MEDLINE
  • 19
    Balkwill FR. Interferons. Lancet 1989; 1:10601063.MEDLINE
  • 20
    Yamada G, Takatani M, Kishi F, Takahashi M, Doi T, Tsuji T, Shin S, et al. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 1995; 22:13511354.MEDLINE
  • 21
    Reddy KR, Weppler D, Zervos XA, Nery JR, Webb MG, Khan MF, Gavlik A, et al. Recurrent HCV infection following OLTx: The role of early post OLTx interferon treatment [Abstract]. Hepatology 1996; 24:295A.
  • 22
    Cacciarelli TV, Martinez OM, Gish RG, Villaneuva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology 1996; 24:69.MEDLINE
  • 23
    Hakozaki Y, Shirahama T, Katou M, Nakagaw K, Oba K, Yoshii O, Matsumoto T, et al. Long-term prognosis of chronic hepatitis C after treatment with interferon alpha-2b and characterization of incomplete responders. Am J Gastroenterol 1996; 91:21452149.
  • 24
    Wright HI, Gavaler JS, Van Theil DH. Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992; 53:121124.MEDLINE
  • 25
    Schiffman ML, Hofmann CM, Luketic VAC, Sanyal AJ, Contos MJ, Mills AS. Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose. Hepatology 1996; 24:2126.MEDLINE
  • 26
    Feray C, Gigou M, Samuel D, Paradis V, Mshiro S, Maertens G, Reynes M, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108:10881096.MEDLINE
  • 27
    Gordon FD, Poterucha JJ, Germer J, Zein NN, Batts KP, Gross JB, Wiesner R, et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997; 63:14191423.MEDLINE
  • 28
    Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, et al. Severe or multiple rejection episodes lead to increased early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21:3034.MEDLINE